Browse
Time

biocept

Trending
Today
Trending
Most Discussed
Most Viewed
Most Agreed
All Ideas
Today
This Week
This Month
All Time
mchedester mchedester BIOC, D, Long ,
BIOC: Biocept - Buy the negativity.  The revenue doesn't mind.
23 1 0
BIOC, D Long
Biocept - Buy the negativity. The revenue doesn't mind.

Biocept has the best-in-breed liquid biopsy testing in the Immuno-Oncology space. Market cap is 70 million, but it's going to be several billion in a few years if they don't get bought out first. Revenue in the second quarter ended 6/30/2016 increased 8 fold to 663,000 from 77,000 last year. This revenue only included half of June for their commerical launch of ...

trademan1 trademan1 BIOC, D, Long ,
BIOC: BIOC Cancer Diagnostics Eliminates Biopsies with Blood Test
363 0 0
BIOC, D Long
BIOC Cancer Diagnostics Eliminates Biopsies with Blood Test

Blood diagnostic OncoCEE-BR was used by Columbia University College of Physicians and Surgeons in New York City to aid cancer patients' diagnosis. Involved biopsies are no longer required, cancer can be detected with a simple blood test. The chart has strong bullish divergence, has just made a breakout with an initial target around 4 dollars.

United States
United Kingdom
India
España
France
Italia
Polska
Brasil
Россия
Türkiye
Indonesia
Malaysia
日本
한국
Home Stock Screener Forex Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing Priority Support Ideas Published Followers Following Private Messages Chat Sign Out